Xponance, Inc. Bionano Genomics, Inc. Transaction History

Xponance, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	BUY	$1.4 - $25.4 $1,209 - $21,945	864 Added 5.33%	17,065 $0
Q3 2022 Oct 24, 2022	BUY	$0.36 - $36.0 $152 - $15,264	424 Added 2.69%	16,201 $30,000
Q2 2022 Aug 02, 2022	BUY	$12.3 - $27.3 $23,542 - $52,252	1,914 Added 13.81%	15,777 $22,000
Q1 2022 Apr 20, 2022	BUY	$16.6 - $32.3 $1,875 - $3,649	113 Added 0.82%	13,863 $36,000
Q4 2021 Jan 31, 2022	BUY	$29.9 - $61.2 $15,189 - $31,089	508 Added 3.84%	13,750 $41,000
Q3 2021 Nov 05, 2021	SELL	$51.4 - $68.2 $110,972 - $147,243	-2,159 Reduced 14.02%	13,242 $73,000
Q2 2021 Aug 12, 2021	BUY	$44.1 - $84.0 $679,184 - $1.29 Million	15,401 New	15,401 $113,000

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $81.2M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.